Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2024-03-05 00:00:00 ET · period of report 2024-03-01 · accession 0001765581-24-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-05 | 2024-03-01 | JAZZ | Johnson Philip L | EVP, CFO | P - Purchase | $119.65 | +12.0K | 27.9K | +75% | +$1.44M | |
| 2024-03-05 | 2024-03-01 | JAZZ | Johnson Philip L | EVP, CFO | A - Grant | $0.00 | +15.9K | 15.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-03-01 | P | A | 12,000 | $119.65 | 27,932 | D | — | — | |
| 2 | Common | Ordinary Shares | 2024-03-01 | A | A | 15,932 | $0.00 | 15,932 | D | — | — |